The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ildstad Suzanne since 2022.
This trader's CIK number is 1845822.
At the time of last reporting, Ildstad Suzanne was the Director of Talaris Therapeutics, Inc.. (stock ticker symbol TALS).
Also see all insider trading activities at Talaris Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | TALS | 0 | $0 | 510,054 | $1,186,084 | 0 | $0 |
| 2022 | TALS | 0 | $0 | 525,000 | $1,470,000 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-12 | TALS | Sale | 16,870 | 2.59 | 43,727 |
| 2023-06-13 | TALS | Sale | 14,208 | 2.56 | 36,344 |
| 2023-06-14 | TALS | Sale | 12,942 | 2.49 | 32,238 |
| 2023-06-09 | TALS | Sale | 25,419 | 2.46 | 62,632 |
| 2023-06-08 | TALS | Sale | 40,642 | 2.48 | 100,792 |
| 2023-06-07 | TALS | Sale | 75,001 | 2.39 | 179,102 |
| 2023-06-06 | TALS | Sale | 25,549 | 2.53 | 64,587 |
| 2023-06-05 | TALS | Sale | 7,841 | 2.52 | 19,751 |
| 2023-06-01 | TALS | Sale | 15,713 | 2.56 | 40,178 |
| 2023-06-02 | TALS | Sale | 15,818 | 2.50 | 39,624 |
| 2023-04-21 | TALS | Sale | 15,004 | 2.35 | 35,229 |
| 2023-04-19 | TALS | Sale | 21,753 | 2.16 | 47,051 |
| 2023-04-20 | TALS | Sale | 46,990 | 2.33 | 109,298 |
| 2023-04-17 | TALS | Sale | 99,771 | 2.14 | 213,509 |
| 2023-04-18 | TALS | Sale | 49,211 | 2.15 | 105,803 |
| 2023-03-17 | TALS | Sale | 10,436 | 2.06 | 21,539 |
| 2023-03-03 | TALS | Sale | 6,806 | 2.06 | 13,993 |
| 2023-03-01 | TALS | Sale | 29 | 2.05 | 59 |
| 2023-02-21 | TALS | Sale | 3,500 | 2.05 | 7,185 |
| 2023-02-16 | TALS | Sale | 2,939 | 2.06 | 6,039 |
| 2023-02-17 | TALS | Sale | 3,612 | 2.05 | 7,404 |
| 2022-08-22 | TALS | Sale | 525,000 | 2.80 | 1,470,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ildstad Suzanne (Director of Talaris Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.